Literature DB >> 16508750

Missense mutations in the BMP15 gene are associated with ovarian failure.

Hridesh Dixit1, Lakshmi K Rao, Venkata V Padmalatha, Murthy Kanakavalli, Mamata Deenadayal, Nalini Gupta, Baidyanath Chakrabarty, Lalji Singh.   

Abstract

Premature ovarian failure (POF) is an unexplained amenorrhoea (>6 months) with raised levels of gonadotropins (FSH>40 U/L) occurring before the age of 40 years. Recent studies have elucidated the role of oocyte derived growth factors (BMP15 and GDF9) in maintenance of folliculogenesis, granulosa cell (GC) proliferation and overall fertility. Our recently published work showed presence of two rare missense variants in the GDF9 gene associated with ovarian failure (Dixit et al. 2005, Menopause 12:749-754). The present case-control study has been structured to establish the role of BMP15 germline status associated with ovarian failure. Sequence analysis of the coding region of the BMP15 gene was carried out in a cohort of women with POF (n=133), primary amenorrhoea (n=60), and secondary amenorrhoea (n=9) compared with control females (n=197). This study revealed a total of 18 germline variants in the coding region of BMP15 gene, including 16 novel variants. These novel variants include one intronic variant, one 3' flanking variant, one silent variant, and 13 missense variants. Eleven missense variants were present only in cases with complete absence in the control females. The remaining two missense variants viz. c.308A>G (p.Asn103Ser) and c.788_789insTCT (p.Leu263_Arg264insLeu) were present both in the cases and in the controls. The c.788_789insTCT variant was significantly higher in primary amenorrhoea cases than in the controls (Fisher's exact test, P=0.034). Three frequent variants c.-9C>G, c.308A>G, and c.852C>T were chosen for haplotyping. The haplotype G-G-C was found to be significantly associated with ovarian failure (P=0.0075). In a nutshell, the BMP15 gene is highly associated with etiology of ovarian failure.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16508750     DOI: 10.1007/s00439-006-0150-0

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  26 in total

1.  Inhibin: a candidate gene for premature ovarian failure.

Authors:  A N Shelling; K A Burton; A L Chand; C C van Ee; J T France; C M Farquhar; S R Milsom; D R Love; K Gersak; K Aittomäki; I M Winship
Journal:  Hum Reprod       Date:  2000-12       Impact factor: 6.918

2.  Growth differentiation factor-9 stimulates inhibin production and activates Smad2 in cultured rat granulosa cells.

Authors:  Jae-Sook Roh; Jonas Bondestam; Sabine Mazerbourg; Noora Kaivo-Oja; Nigel Groome; Olli Ritvos; Aaron J W Hsueh
Journal:  Endocrinology       Date:  2003-01       Impact factor: 4.736

Review 3.  Molecular biology and physiological role of the oocyte factor, BMP-15.

Authors:  R Kelly Moore; Shunichi Shimasaki
Journal:  Mol Cell Endocrinol       Date:  2005-04-29       Impact factor: 4.102

4.  Synergistic roles of bone morphogenetic protein 15 and growth differentiation factor 9 in ovarian function.

Authors:  C Yan; P Wang; J DeMayo; F J DeMayo; J A Elvin; C Carino; S V Prasad; S S Skinner; B S Dunbar; J L Dube; A J Celeste; M M Matzuk
Journal:  Mol Endocrinol       Date:  2001-06

5.  Disruption of human limb morphogenesis by a dominant negative mutation in CDMP1.

Authors:  J T Thomas; M W Kilpatrick; K Lin; L Erlacher; P Lembessis; T Costa; P Tsipouras; F P Luyten
Journal:  Nat Genet       Date:  1997-09       Impact factor: 38.330

6.  Functional and molecular characterization of naturally occurring mutations in the oocyte-secreted factors bone morphogenetic protein-15 and growth and differentiation factor-9.

Authors:  Wu Xiang Liao; R Kelly Moore; Shunichi Shimasaki
Journal:  J Biol Chem       Date:  2004-02-17       Impact factor: 5.157

7.  Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure.

Authors:  K Aittomäki; J L Lucena; P Pakarinen; P Sistonen; J Tapanainen; J Gromoll; R Kaskikari; E M Sankila; H Lehväslaiho; A R Engel; E Nieschlag; I Huhtaniemi; A de la Chapelle
Journal:  Cell       Date:  1995-09-22       Impact factor: 41.582

8.  Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (BMP15) gene.

Authors:  Elisa Di Pasquale; Paolo Beck-Peccoz; Luca Persani
Journal:  Am J Hum Genet       Date:  2004-05-10       Impact factor: 11.025

9.  The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome.

Authors:  L Crisponi; M Deiana; A Loi; F Chiappe; M Uda; P Amati; L Bisceglia; L Zelante; R Nagaraja; S Porcu; M S Ristaldi; R Marzella; M Rocchi; M Nicolino; A Lienhardt-Roussie; A Nivelon; A Verloes; D Schlessinger; P Gasparini; D Bonneau; A Cao; G Pilia
Journal:  Nat Genet       Date:  2001-02       Impact factor: 38.330

Review 10.  Genes and translocations involved in POF.

Authors:  David Schlessinger; Luisa Herrera; Laura Crisponi; Steven Mumm; Antonio Percesepe; Massimo Pellegrini; Giuseppe Pilia; Antonino Forabosco
Journal:  Am J Med Genet       Date:  2002-08-15
View more
  51 in total

Review 1.  Bidirectional communication between oocytes and follicle cells: ensuring oocyte developmental competence.

Authors:  Gerald M Kidder; Barbara C Vanderhyden
Journal:  Can J Physiol Pharmacol       Date:  2010-04       Impact factor: 2.273

2.  A large bioactive BMP ligand with distinct signaling properties is produced by alternative proconvertase processing.

Authors:  Takuya Akiyama; Guillermo Marqués; Kristi A Wharton
Journal:  Sci Signal       Date:  2012-04-03       Impact factor: 8.192

3.  A mutation in the nucleoporin-107 gene causes XX gonadal dysgenesis.

Authors:  Ariella Weinberg-Shukron; Paul Renbaum; Rachel Kalifa; Sharon Zeligson; Ziva Ben-Neriah; Amatzia Dreifuss; Amal Abu-Rayyan; Noa Maatuk; Nilly Fardian; Dina Rekler; Moien Kanaan; Abraham O Samson; Ephrat Levy-Lahad; Offer Gerlitz; David Zangen
Journal:  J Clin Invest       Date:  2015-10-20       Impact factor: 14.808

4.  Regulation of AMH by oocyte-specific growth factors in human primary cumulus cells.

Authors:  Scott Convissar; Marah Armouti; Michelle A Fierro; Nicola J Winston; Humberto Scoccia; A Musa Zamah; Carlos Stocco
Journal:  Reproduction       Date:  2017-09-05       Impact factor: 3.906

Review 5.  The function of bone morphogenetic proteins in the human ovary.

Authors:  Osamu Yoshino; Jia Shi; Yutaka Osuga; Miyuki Harada; Osamu Nishii; Tetsu Yano; Yuji Taketani
Journal:  Reprod Med Biol       Date:  2011-01-06

Review 6.  Unique bioactivities of bone morphogenetic proteins in regulation of reproductive endocrine functions.

Authors:  Fumio Otsuka; Kenichi Inagaki
Journal:  Reprod Med Biol       Date:  2011-04-14

7.  Growth differentiation factor 9:bone morphogenetic protein 15 heterodimers are potent regulators of ovarian functions.

Authors:  Jia Peng; Qinglei Li; Karen Wigglesworth; Adithya Rangarajan; Chandramohan Kattamuri; Randall T Peterson; John J Eppig; Thomas B Thompson; Martin M Matzuk
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

Review 8.  The primordial pool of follicles and nest breakdown in mammalian ovaries.

Authors:  Candace Tingen; Alison Kim; Teresa K Woodruff
Journal:  Mol Hum Reprod       Date:  2009-08-26       Impact factor: 4.025

Review 9.  The menstrual cycle: basic biology.

Authors:  Shannon M Hawkins; Martin M Matzuk
Journal:  Ann N Y Acad Sci       Date:  2008       Impact factor: 5.691

10.  Phosphorylation of bone morphogenetic protein-15 and growth and differentiation factor-9 plays a critical role in determining agonistic or antagonistic functions.

Authors:  Heather E McMahon; Shweta Sharma; Shunichi Shimasaki
Journal:  Endocrinology       Date:  2007-11-15       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.